[Trabecular bone score in rheumatology : Are there benefits in comparison to bone densitometry alone?]
- PMID: 37646845
- DOI: 10.1007/s00393-023-01407-5
[Trabecular bone score in rheumatology : Are there benefits in comparison to bone densitometry alone?]
Abstract
Patients with inflammatory rheumatic diseases have an increased risk of fractures due to the inflammatory potential of the disease and also because of the treatment with glucocorticoids that is often necessary. According to the current guidelines of the Governing Body on Osteology (DVO), the fracture risk can be assessed using dual energy X‑ray absorptiometry and can also be supplemented by measuring the trabecular bone score (TBS). The assessment of the TBS offers additional advantages, for example in glucocorticoid-induced osteoporosis and in patients with osteoproliferative changes of the spine (spondylarthritis) and thus optimizes the fracture risk assessment in the rheumatological patient population.
Patient*innen mit entzündlich rheumatischen Erkrankungen weisen aufgrund des Entzündungspotenzials ihrer Erkrankung, aber auch wegen der oft notwendigen Glukokortikoidbehandlung ein erhöhtes Frakturrisiko auf. Die Abschätzung des Frakturrisikos erfolgt nach aktueller DVO(Dachverband Osteologie)-Leitlinie auch mittels „dual-energy X‑ray absorptiometry“, diese kann auch durch die Bestimmung des Trabecular Bone Score (TBS) ergänzt werden. Die Erhebung von TBS bringt zusätzliche Vorteile z. B. bei der Glukokortikoid-induzierten Osteoporose, aber auch bei Patient*innen mit osteoproliferativen Veränderungen an der Wirbelsäule (Spondylarthritiden) und optimiert somit im rheumatologischen Patientengut die Frakturrisikoabschätzung.
Keywords: Bone; Bone density; Densitometry, bone; Dual-energy X‑ray absorptiometry; Fractures.
© 2023. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.
Similar articles
-
The impact of glucocorticoid therapy on trabecular bone score in older women.Osteoporos Int. 2015 Jun;26(6):1773-80. doi: 10.1007/s00198-015-3078-1. Epub 2015 Mar 6. Osteoporos Int. 2015. PMID: 25743176
-
[Evaluation of the trabecular bone score (TBS) in routine clinical care of patients with inflammatory rheumatic and non-inflammatory diseases : Correlation with conventional bone mineral density measurement and prevalence of vertebral fractures].Z Rheumatol. 2020 Dec;79(10):1067-1074. doi: 10.1007/s00393-020-00764-9. Z Rheumatol. 2020. PMID: 32162022 Free PMC article. German.
-
Use of Trabecular Bone Score (TBS) as a Complementary Approach to Dual-energy X-ray Absorptiometry (DXA) for Fracture Risk Assessment in Clinical Practice.J Clin Densitom. 2017 Jul-Sep;20(3):334-345. doi: 10.1016/j.jocd.2017.06.019. Epub 2017 Jul 19. J Clin Densitom. 2017. PMID: 28734710 Review.
-
Clinical Utility of Trabecular Bone Score (TBS) in Fracture Risk Assessment of Patients with Rheumatic Diseases Treated with Glucocorticoids.Horm Metab Res. 2021 Aug;53(8):499-503. doi: 10.1055/a-1528-7261. Epub 2021 Aug 12. Horm Metab Res. 2021. PMID: 34384106
-
Trabecular Bone Score in Rheumatic Disease.Curr Rheumatol Rep. 2022 Apr;24(4):81-87. doi: 10.1007/s11926-022-01062-w. Epub 2022 Mar 25. Curr Rheumatol Rep. 2022. PMID: 35334058 Review.
References
Literatur
-
- Konnopka A, Jerusel N, König HH (2009) The health and economic consequences of osteopenia- and osteoporosis-attributable hip fractures in Germany: estimation for 2002 and projection until 2050. Osteoporos Int 20(7):1117–1129 - PubMed
-
- Rossini M, Viapiana O, Vitiello M, Malavolta N, La Montagna G, Maddali Bongi S et al (2017) Prevalence and incidence of osteoporotic fractures in patients on long-term glucocorticoid treatment for rheumatic diseases: the Glucocorticoid Induced OsTeoporosis TOol (GIOTTO) study. Reumatismo 69(1):30–39 - PubMed
-
- Cetin B, Cetin EA, Arikan H, Velioglu A, Alibaz-Oner F, Direskeneli H et al (2021) FRAX scores are increased in patients with ANCA-associated vasculitis. Int Urol Nephrol 53(11):2333–2339 - PubMed
-
- Chen J, Lei L, Pan J, Zhao C (2020) A meta-analysis of fracture risk and bone mineral density in patients with systemic sclerosis. Clin Rheumatol 39(4):1181–1189 - PubMed
-
- Molto A, Etcheto A, van der Heijde D, Landewe R, van den Bosch F, Bautista Molano W et al (2016) Prevalence of comorbidities and evaluation of their screening in spondyloarthritis: results of the international cross-sectional ASAS-COMOSPA study. Ann Rheum Dis 75(6):1016–1023 - PubMed
Publication types
LinkOut - more resources
Full Text Sources